Overview

Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects

Status:
COMPLETED
Trial end date:
2024-12-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the influence of HRS9531 injection on pharmacokinetics of metformin in healthy subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Fujian Shengdi Pharmaceutical Co., Ltd.
Treatments:
Metformin